Eco Animal Health Group (STU:LWA) ROCE % : -2.26% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Eco Animal Health Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Eco Animal Health Group's annualized ROCE % for the quarter that ended in Sep. 2024 was -2.26%.

Eco Animal Health Group ROCE % Historical Data

The historical data trend for Eco Animal Health Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eco Animal Health Group ROCE % Chart

Eco Animal Health Group Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

7.43

22.45

1.76

5.09

3.85

Eco Animal Health Group Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
ROCE %	Get a 7-Day Free Trial															6.45	3.90	-0.96	8.79	-2.26

Eco Animal Health Group ROCE % Calculation

Eco Animal Health Group's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	4.37	/	( ( (137.51 - 25.127)	+	(144.096 - 29.49) )	/ 2 )
	=	4.37	/	( (112.383	+	114.606)	/ 2 )
	=	4.37	/	113.4945
	=	3.85 %

Eco Animal Health Group's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2024 )		(Q: Sep. 2024 )
	=	-2.576	/	( ( (144.096 - 29.49)	+	(133.159 - 20.104) )	/ 2 )
	=	-2.576	/	( ( 114.606	+	113.055 )	/ 2 )
	=	-2.576	/	113.8305
	=	-2.26 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2024) EBIT data.

Eco Animal Health Group (STU:LWA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Eco Animal Health Group ROCE % Related Terms

Thank you for viewing the detailed overview of Eco Animal Health Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Eco Animal Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eco Animal Health Group PLC (STU:LWA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

EAH:UK LWA:Germany

Address

100 High street, The Grange, Southgate, London, GBR, N14 6BN

Website

https://www.ecoanimalhealth.com

Eco Animal Health Group PLC is engaged in manufacturing and marketing animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The company's geographical segments include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World. Maximum revenue for the company is generated from China and Japan.

Eco Animal Health Group Headlines

No Headlines